Article
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis
by
Robert J. Fox;
Christopher S. Coffey;
Merit E. Cudkowicz;
Trevis Gleason;
Andrew Goodman;
Eric C. Klawiter;
Kazuko Matsuda;
Michelle McGovern;
Robin Conwit;
Jai Perumal;
Michael Racke;
Pavle Repovic;
Claire Riley;
Christopher Severson;
Shlomo Shinnar;
Valerie Suski;
Bianca Weinstock-Gutman;
Vijayshree Yadav;
Aram Zabeli;
Robert Naismith;
Akshata Ashokkumar;
Robert Bermel;
Dixie Ecklund;
Maxine Koepp;
Jeffrey Long;
Sneha Natarajan;
Srividya Ramachandran;
Thomai Skaramagas;
Brenda Thornell;
Jon Yankey;
Mark Agius;
Khurram Bashir;
Bruce Cohen;
Patricia Coyle ;
Silvia Delgado;
Dana Dewitt;
Angela Flores;
Barbara Giesser;
Myla Goldman;
Burk Jubelt;
Neil Lava;
Sharon Lynch;
Augusto Miravalle;
Harold Moses;
Daniel Ontaneda
2016